Katherine McAllister

Policy, programs and capacity needed for environmental improvements, as part of the federal budget process. Policy, programs and capacity with respect to improving health for all people in Canada and addressing climate change. Policies, programs and capacity needed for implementation of the National Adaptation Strategy Policies, programs and capacity for implementation of the Environmental Justice Strategy The Canadian Environmental Protection Act, with respect to improving health and wellbeing for all people in Canada including those most vulnerable Legislation proposal and regulations (eg to the Competition Act, Canadian Environmental Protection Act, Canadian Code of Advertising Standards, etc) to restrict/ban advertising of fossil fuels.

Lobbying for the preservation of affordable rental housing Lobbying for the development of new affordable housing, including co-operative housing. Lobbying to ensure that low-income households can continue to live affordably in federally-administered housing co-operatives after their operating agreements end with Canada Mortgage and Housing Corporation (CMHC). Lobbying for renewed low-income subsidies for federal indigenous co-operatives. Lobbying for new low-income subsidies for federal co-ops (including Section 95 program co-op housing). Lobbying for government to examine the consequences of the steady erosion of rent-geared-to-income (RGI) capacity for low-income households in existing federally administered housing providers, including co-operatives. Lobbying for energy retrofit programs for co-op housing. Lobbying around the elimination of homelessness in Canada.

Seeking the establishment of a federal Canada Water Agency Seeking legislation for a public, universal pharmacare program Seeking just transition legislation that protects workers, communities, and the planet. Seeking a national citizens' assembly on electoral reform so each vote has equal value and there is increased government accountability to all citizens Advocating for all remaining drinking water advisories in First Nations communities to be addressed and lifted

Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations Food and Drug regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canada's Drug Agency (CDA) policies as it relates to health economics assessment and recommendations made on new medicines. Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations. Free Trade agreements as they relate to the biopharmaceutical industry Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19. Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution. Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.

Postal service disruption and the significant hardships these disruptions cause for Canadians and on health charities We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Safe Long-Term Care Act with respect to persons affected by MS National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities Measures and funding for the charitable sector generally Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions. Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities CIHR as it relates to federal funding & long term investment in health research Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care Canada Health Act and regulations, as it relates to long-term and home care Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

Universal Pharmacare - We advocate for universal national single payer program for prescription medication that would improve coverage across Canada and result in logistical efficiencies for the system. The importance of family medicine research and the impact it has on family medicine, primary care and the health care system. Want to ensure that family medicine research is acknowledged by federal officials as requiring sufficient supports. Scopes of Practice and collaborative care: support for enhanced intra- and inter-professional collaboration Public Health: support for family physician involvement in not only playing a pivotal role in the delivery of public health but also in planning for public health emergencies. Family physicians and their practices are essential in contributing pandemic response and are fundamental partners in supporting large-scale vaccination rollout in all provinces and territories - both as a source of accurate information and delivery points for vaccines. Patient's Medical Home (PMH): identified by its patients as the place that serves as the home base or central hub for the timely provision and/or coordination of all their health and medical care needs. Implementation of PMH is desired across Canada, including appropriate integration of virtual care and its application as a part of longitudinal relationship-based care in alignment with the PMH vision. Looking for support for and understanding of the role of social determinants of health (SDoH) and how these determinants, such as poverty, impact Canadians. The CFPC continues to call attention to SDoH, the role family physicians play and the expectations we have of federal decision-makers to acknowledge SDoH when crafting policies and programs. Indigenous Health: support for health care initiatives and education that improve health outcomes for Indigenous people of Canada and address the adverse effects of systemic racism, in line with the Truth and Reconciliation Commission of Canada’s calls for action. The CFPC maintains strong support of the proposed National Consortium for Indigenous Medical Education involving medical learners, educators, and physicians to ensure that training and continued professional development in caring for Indigenous patients are delivered through a lens of cultural humility and cultural safety. Health Human Resources: encourage support for the College of Family Physician's goal of every Canadian having their own family physician. The College of Family Physicians of Canada is also recommending increased federal support for a pan-Canadian health human resources plan to strengthen primary care. Investment into Primary Health Care Transition Fund would help improve Canada-wide access to family practices and allied primary care.